Novel canonical and non-canonical viral antigens extend current targets for immunotherapy of HPV-driven cervical cancer.

MLA

Peng, Xu, et al. “Novel Canonical and Non-Canonical Viral Antigens Extend Current Targets for Immunotherapy of HPV-Driven Cervical Cancer.” IScience, vol. 26, no. 3, Feb. 2023, p. 106101. EBSCOhost, https://doi.org/10.1016/j.isci.2023.106101.

APA

Peng, X., Woodhouse, I., Hancock, G., Parker, R., Marx, K., Müller, J., Salatino, S., Partridge, T., Nicastri, A., Liao, H., Kruppa, G., Hellner, K., Dorrell, L., & Ternette, N. (2023). Novel canonical and non-canonical viral antigens extend current targets for immunotherapy of HPV-driven cervical cancer. IScience, 26(3), 106101. https://doi.org/10.1016/j.isci.2023.106101

Chicago

Peng, Xu, Isaac Woodhouse, Gemma Hancock, Robert Parker, Kristina Marx, Julius Müller, Silvia Salatino, et al. 2023. “Novel Canonical and Non-Canonical Viral Antigens Extend Current Targets for Immunotherapy of HPV-Driven Cervical Cancer.” IScience 26 (3): 106101. doi:10.1016/j.isci.2023.106101.